Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation and immune dysfunction in Parkinson disease
Malú G. Tansey, Rebecca L. Wallings, Madelyn C. Houser, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 11, pp. 657-673
Open Access | Times Cited: 775

Showing 26-50 of 775 citing articles:

Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
Wendy Balestri, Ruchi Sharma, Victor Allisson da Silva, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects
Bin Tong, Yaoqi Ba, Zhengyang Li, et al.
Neurobiology of Disease (2024) Vol. 196, pp. 106505-106505
Open Access | Times Cited: 15
Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration
Zahra Razavi, Seyed Sina Alizadeh, F. S. Razavi, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125186-125186
Open Access | Times Cited: 5
Associations Between Diabetes Mellitus and Neurodegenerative Diseases
Leszek Szablewski
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 542-542
Open Access | Times Cited: 2
Recent advances in nanotechnology for Parkinson’s disease: diagnosis, treatment, and future perspectives
Virendra Kumar Yadav, Seshathiri Dhanasekaran, Nisha Choudhary, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access | Times Cited: 2
Microbiota-immune-brain interactions: A lifespan perspective
Anna Ratsika, Joana S. Cruz Pereira, Caoimhe M.K. Lynch, et al.
Current Opinion in Neurobiology (2022) Vol. 78, pp. 102652-102652
Open Access | Times Cited: 51
The Gut Microbiome–Brain Crosstalk in Neurodegenerative Diseases
Laura Ghezzi, Claudia Cantoni, Emanuela Rotondo, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1486-1486
Open Access | Times Cited: 41
Sarcopenia and nervous system disorders
Jie Yang, Feifei Jiang, Ming Yang, et al.
Journal of Neurology (2022) Vol. 269, Iss. 11, pp. 5787-5797
Closed Access | Times Cited: 39
Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease
Paola Imbriani, Giuseppina Martella, Paola Bonsi, et al.
Neurobiology of Disease (2022) Vol. 173, pp. 105851-105851
Open Access | Times Cited: 39
GSK-3β: An exuberating neuroinflammatory mediator in Parkinson's disease
Sabiya Samim Khan, Sushmita Janrao, Saurabh Srivastava, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115496-115496
Open Access | Times Cited: 39
Inflammasome assembly in neurodegenerative diseases
Jagjit Singh, Maria L. Habean, Nikhil Panicker
Trends in Neurosciences (2023) Vol. 46, Iss. 10, pp. 814-831
Open Access | Times Cited: 39
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
Qiu-Qin Han, Weidong Le
Neuroscience Bulletin (2023) Vol. 39, Iss. 5, pp. 832-844
Open Access | Times Cited: 36
Lactate metabolism in neurodegenerative diseases
Chaoguang Yang, Rui‐Yuan Pan, Fangxia Guan, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 1, pp. 69-74
Open Access | Times Cited: 35
Bioactive Compounds of the Mediterranean Diet as Nutritional Support to Fight Neurodegenerative Disease
Gianluca Antonio Franco, Livia Interdonato, Marika Cordaro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7318-7318
Open Access | Times Cited: 34
Gut-microbiome-brain axis: the crosstalk between the vagus nerve, alpha-synuclein and the brain in Parkinson’s disease
Júlio César Claudino dos Santos, Leandro Freitas Oliveira, Felipe Micelli Noleto, et al.
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2611-2614
Open Access | Times Cited: 34
The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
Jacob Deyell, Manjari Sriparna, Mingyao Ying, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2477-2477
Open Access | Times Cited: 33
Deficient chaperone-mediated autophagy facilitates LPS-induced microglial activation via regulation of the p300/NF-κB/NLRP3 pathway
Wu Jin, Yingying Han, Hao Xu, et al.
Science Advances (2023) Vol. 9, Iss. 40
Open Access | Times Cited: 33
Brain and Systemic Inflammation in De Novo Parkinson's Disease
Talene A. Yacoubian, Yu-Hua Fang, Adam Gerstenecker, et al.
Movement Disorders (2023) Vol. 38, Iss. 5, pp. 743-754
Open Access | Times Cited: 32
Microglia and Astrocytes Dysfunction and Key Neuroinflammation-Based Biomarkers in Parkinson’s Disease
Kun Chen, Haoyang Wang, Iqra Ilyas, et al.
Brain Sciences (2023) Vol. 13, Iss. 4, pp. 634-634
Open Access | Times Cited: 32
The Endotoxin Hypothesis of Parkinson's Disease
Guy C. Brown, Marta Camacho, Caroline H. Williams‐Gray
Movement Disorders (2023) Vol. 38, Iss. 7, pp. 1143-1155
Open Access | Times Cited: 29
Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence
Xiaoyan Liu, Yi Liu, Junlin Liu, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 4, pp. 833-845
Open Access | Times Cited: 29
Associations between gut microbiota and Parkinson disease: A bidirectional Mendelian randomization analysis
Jiang Li, Jinchen Li, Beisha Tang, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 11, pp. 3471-3477
Closed Access | Times Cited: 28
Peripheral inflammatory immune response differs among sporadic and familial Parkinson’s disease
Laura Muñoz‐Delgado, Daniel Macías‐García, María Teresa Periñán, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 27
Translational molecular imaging and drug development in Parkinson’s disease
Ahmed Haider, Nehal H. Elghazawy, Alyaa Dawoud, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 27
Increased Risk of Aging-Related Neurodegenerative Disease after Traumatic Brain Injury
Sarah Barker, Bindu D. Paul, Andrew A. Pieper
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1154-1154
Open Access | Times Cited: 27

Scroll to top